SCHEMBL16617713

SCHEMBL16617713

CC(=O)[C@H]1CC(F)(F)CC[C@H]1C(=O)Cc1ccc(C(=O)O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 4/20 0.38
ALDH1A1 P00352 2/20 0.36
RXRA P19793 3/20 0.36
KMT2A Q03164 4/20 0.35
RXRB P28702 2/20 0.35
MEN1 O00255 2/20 0.35
RXRG P48443 1/20 0.35
KCNQ3 O43525 2/20 0.35
KCNQ2 O43526 2/20 0.35
KCNQ4 P56696 1/20 0.35
KCNQ5 Q9NR82 1/20 0.35
MAOA P21397 1/20 0.34
TEAD1 P28347 1/20 0.34
TEAD4 Q15561 1/20 0.34
TEAD2 Q15562 1/20 0.34
USP2 O75604 2/20 0.33
HRH3 Q9Y5N1 1/20 0.32
SRD5A2 P31213 2/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16617711 1.00 PTGER4 (0.38) PTGER4ALDH1A1RXRAKMT2ARXRB
SCHEMBL16617178 0.87 PTGER4 (0.38) PTGER4ALDH1A1RXRAKMT2ARXRB
SCHEMBL16617175 0.87 PTGER4 (0.38) PTGER4ALDH1A1RXRAKMT2ARXRB
SCHEMBL16618089 0.74 KDM1A (0.37) ALDH1A1KMT2AMEN1
SCHEMBL16617541 0.73 ABL1 (0.45) ALDH1A1KMT2AHRH3POLBGAA
SCHEMBL16617949 0.70 HPGD (0.44) ALDH1A1KMT2AHRH3POLBGAA
SCHEMBL16617950 0.70 HPGD (0.44) ALDH1A1KMT2AHRH3POLBGAA
SCHEMBL16624856 0.69 KMT2A (0.43) ALDH1A1RXRAKMT2ARXRBRXRG
SCHEMBL5646773 0.68 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1USP2SRD5A2
SCHEMBL3494372 0.66 S1PR4 (0.45) KCNQ3KCNQ2KCNQ4KCNQ5SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458181-B2 Cathepsin cysteine protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-04 US disclosed
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS CTSB, CTSS, CTSZ PTGER4 3732/4885ALDH1A1 4582/4885RXRA 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.